Merck MRK
NYSE MRK
$152.52 +3.53 (+2.37%)
As of: Aug 21, 2026 · 3:59 PM EDT

Merck (MRK) Common Equity (2009 - 2026)

Merck (MRK) posted quarterly Common Equity of $109.6 billion for Q1 2026, up 126.5% year-over-year from $48.4 billion in Q1 2025, and up 108.39% quarter-over-quarter from $52.6 billion in Q4 2025.

Merck (MRK) Common Equity (2009 - 2026) Analysis & Trends

Merck (MRK) has reported Common Equity for 18 consecutive years, with $109.6 billion the latest figure, recorded in Q1 2026.

  • In Q1 2026, Common Equity rose 126.5% year-over-year to $109.6 billion; the TTM figure through Mar 2026 stood at $109.6 billion (up 126.5% YoY), while the FY2025 annual figure was $52.6 billion, up 13.44% from the prior year.
  • Common Equity advanced to $109.6 billion in Q1 2026 per MRK's latest filing, from $52.6 billion in the prior quarter.
  • Across five years, Common Equity topped out at $113.6 billion in Q3 2025 and bottomed at $37.6 billion in Q4 2023.
  • Historically, Common Equity has averaged $52.2 billion across 5 years, with a median of $44.6 billion in 2024.
  • Annual changes were most pronounced in 2023 — Common Equity decreased 18.29% — and 2025, when it jumped 155.05%.
  • Merck's Common Equity stood at $46.1 billion in 2022, then retreated by 18.29% to $37.6 billion in 2023, then increased by 23.22% to $46.4 billion in 2024, then climbed by 13.44% to $52.6 billion in 2025, then jumped by 108.39% to $109.6 billion in 2026.
  • Business Quant data shows MRK's Common Equity at $109.6 billion in Q1 2026, $52.6 billion in Q4 2025, and $113.6 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Johnson & Johnson 652.20 Bn 631.44 Bn 17.26 Bn 84.97 Bn
2 AbbVie 469.51 Bn 462.94 Bn 12.70 Bn -5.94 Bn
3 Merck 376.81 Bn 369.67 Bn 12.21 Bn 106.07 Bn
4 Novartis Ag 303.04 Bn 295.35 Bn 11.24 Bn 41.95 Bn
5 Astrazeneca 257.61 Bn 252.71 Bn 12.86 Bn 50.37 Bn
6 Amgen 237.37 Bn 223.38 Bn 7.24 Bn 11.69 Bn
7 Gilead Sciences 181.73 Bn 178.55 Bn 6.22 Bn 11.83 Bn
8 Pfizer 159.66 Bn 147.96 Bn 10.94 Bn 85.49 Bn
9 Gsk 106.24 Bn 102.07 Bn 8.24 Bn 23.05 Bn
10 Sanofi 55.07 Bn 47.69 Bn 10.79 Bn 80.86 Bn

Historic Data

Download Data
DateValue
Jun 30, 2026 106.07 Bn
Mar 31, 2026 109.63 Bn
Dec 31, 2025 52.61 Bn
Sep 30, 2025 113.65 Bn
Jun 30, 2025 49.06 Bn
Mar 31, 2025 48.40 Bn
Dec 31, 2024 46.37 Bn
Sep 30, 2024 44.56 Bn
Jun 30, 2024 43.65 Bn
Mar 31, 2024 40.42 Bn
Dec 31, 2023 37.64 Bn
Sep 30, 2023 41.30 Bn
Jun 30, 2023 38.74 Bn
Mar 31, 2023 46.91 Bn
Dec 31, 2022 46.06 Bn
Sep 30, 2022 44.52 Bn
Jun 30, 2022 43.32 Bn
Mar 31, 2022 40.95 Bn
Dec 31, 2021 38.26 Bn
Sep 30, 2021 35.86 Bn